Standard Chem & Pharm CO., LTD.

Taiwan Stock Exchange 1720.TW

Standard Chem & Pharm CO., LTD. Free Cash Flow for the year ending December 31, 2023: USD 23.15 M

Standard Chem & Pharm CO., LTD. Free Cash Flow is USD 23.15 M for the year ending December 31, 2023, a 2,243.20% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Standard Chem & Pharm CO., LTD. Free Cash Flow for the year ending December 31, 2022 was USD 988.16 K, a -95.50% change year over year.
Standard Chem & Pharm CO., LTD. Free Cash Flow for the year ending December 31, 2021 was USD 21.97 M, a 8.41% change year over year.
Standard Chem & Pharm CO., LTD. Free Cash Flow for the year ending December 31, 2020 was USD 20.27 M, a 32.14% change year over year.
Standard Chem & Pharm CO., LTD. Free Cash Flow for the year ending December 31, 2019 was USD 15.34 M, a 48.64% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Taiwan Stock Exchange: 1720.TW

Standard Chem & Pharm CO., LTD.

CEO	Mr. Tzu-Ting Fan
IPO Date	Jan. 4, 2000
Location	Taiwan
Headquarters	No. 6-20, Tuku
Employees	1,130
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.

Key trends

Past 5 years